Wall Street Analyst Downgrade Revance Therapeutics Inc [RVNC]. What else is Wall St. saying
Revance Therapeutics Inc [NASDAQ: RVNC] closed the trading session at $3.47. The stocks have a year to date performance of 14.14 percent and weekly performance of 13.40 percent. The stock has been moved at 24.15 percent over the last six months. The stock has performed